Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Q2 skin care sales

Executive Summary

Strong growth of Neutrogena outside the U.S. and strength of Clean & Clear and Aveeno in all markets drive 10.8% growth in second quarter skin care sales, Johnson & Johnson reports during presentation to analysts July 16. Global skin care sales in the period reached $400 mil., while U.S. skin care sales rose 10.2% to $206 mil., according to the company. Worldwide Consumer segment sales, including the skin care, baby care, McNeil and women's health businesses, grew 7.8% to $1.65 bil. in Q2, with U.S. sales up 12.4% to $907 mil., the firm reports in a 1July 16 release...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS010467

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel